Silk Road Medical Inc. (SILK) Financial Statements (2024 and earlier)

Company Profile

Business Address 1213 INNSBRUCK DR.
SUNNYVALE, CA 94089-2918
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:190,203213,474110,231147,48290,689
Cash and cash equivalents20,210 110,23169,46639,181
Short-term investments161,264158,316 78,01651,508
Other undisclosed cash, cash equivalents, and short-term investments8,72955,158   
Receivables23,57318,15511,9199,1418,703
Inventory, net of allowances, customer advances and progress billings29,87619,29317,8519,98910,322
Inventory29,87619,29317,8519,98910,322
Other undisclosed current assets(2,817)3,9763,3256,7162,776
Total current assets:240,835254,898143,326173,328112,490
Noncurrent Assets
Property, plant and equipment8,1149,3727,6972,8442,734
Long-term investments and receivables9,456   18,224
Long-term investments9,456   18,224
Restricted cash and investments  155232310310
Other noncurrent assets6,9045,2605,3702,8323,644
Total noncurrent assets:24,47414,78713,2995,98624,912
TOTAL ASSETS:265,309269,685156,625179,314137,402
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30,28324,48822,18119,55516,932
Accounts payable5,6762,5232,3792,5981,898
Accrued liabilities24,60721,96519,80216,95715,034
Debt   3,905  
Total current liabilities:30,28324,48826,08619,55516,932
Noncurrent Liabilities
Long-term debt and lease obligation75,62674,59644,78648,53344,879
Long-term debt, excluding current maturities75,62674,59644,78648,53344,879
Liabilities, other than long-term debt8,2496,7266,5133,7263,700
Other liabilities8,2496,7266,5133,7263,700
Total noncurrent liabilities:83,87581,32251,29952,25948,579
Total liabilities:114,158105,81077,38571,81465,511
Equity
Equity, attributable to parent151,151163,87579,240107,50071,891
Common stock3938353431
Additional paid in capital550,495507,715367,907346,318263,384
Accumulated other comprehensive income (loss)72(166) 392
Accumulated deficit(399,455)(343,712)(288,702)(238,891)(191,526)
Total equity:151,151163,87579,240107,50071,891
TOTAL LIABILITIES AND EQUITY:265,309269,685156,625179,314137,402

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues177,134138,638101,47575,22763,354
Cost of revenue
(Cost of Goods and Services Sold)
(50,048)(37,876)(25,446)(21,291)(15,927)
Gross profit:127,086100,76276,02953,93647,427
Operating expenses(186,357)(152,766)(123,497)(96,795)(75,492)
Operating loss:(59,271)(52,004)(47,468)(42,859)(28,065)
Nonoperating income (expense)10,3992,3371751,024(19,398)
Investment income, nonoperating9,9572,5271981,1041,656
Other nonoperating income (expense)442(190)(23)(80)(21,054)
Interest and debt expense(6,871)(5,343)(2,518)(5,530)(4,952)
Loss from continuing operations before income taxes:(55,743)(55,010)(49,811)(47,365)(52,415)
Income tax expense (43)(29)(20)(11)(8)
Other undisclosed loss from continuing operations     
Loss from continuing operations:(55,786)(55,039)(49,831)(47,376)(52,423)
Loss before gain (loss) on sale of properties:(49,831)(47,376)(52,423)
Other undisclosed net income432920118
Net loss available to common stockholders, diluted:(55,743)(55,010)(49,811)(47,365)(52,415)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(55,743)(55,010)(49,811)(47,365)(52,415)
Other comprehensive income     2
Comprehensive loss:(55,743)(55,010)(49,811)(47,365)(52,413)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent238(166)(39)37 
Comprehensive loss, net of tax, attributable to parent:(55,505)(55,176)(49,850)(47,328)(52,413)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: